(Q63229203)
Statements
Safety and Efficacy of Immuno-modulation and Autologous Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Multiple Sclerosis. (English)
0 references
July 2016
0 references
September 2020
0 references
50
0 references